WallStSmart

Boston Scientific Corp (BSX)vsThe Home Depot Inc (HD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Home Depot Inc generates 720% more annual revenue ($164.68B vs $20.07B). BSX leads profitability with a 14.4% profit margin vs 8.6%. BSX appears more attractively valued with a PEG of 0.75. BSX earns a higher WallStSmart Score of 63/100 (C+).

BSX

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.5Value: 8.7Quality: 5.5
Piotroski: 4/9

HD

Hold

50

out of 100

Grade: D+

Growth: 2.7Profit: 7.5Value: 4.7Quality: 5.8
Piotroski: 2/9Altman Z: 3.82
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSXUndervalued (+3.0%)

Margin of Safety

+3.0%

Fair Value

$70.25

Current Price

$68.15

$2.10 discount

UndervaluedFair: $70.25Overvalued
HDSignificantly Overvalued (-241.7%)

Margin of Safety

-241.7%

Fair Value

$96.83

Current Price

$330.91

$234.08 premium

UndervaluedFair: $96.83Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSX4 strengths · Avg: 8.3/10
Market CapQuality
$103.10B9/10

Large-cap with strong market position

PEG RatioValuation
0.758/10

Growing faster than its price suggests

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

HD4 strengths · Avg: 9.5/10
Market CapQuality
$319.31B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
145.5%10/10

Every $100 of equity generates 146 in profit

Altman Z-ScoreHealth
3.8210/10

Safe zone — low bankruptcy risk

Free Cash FlowQuality
$2.29B8/10

Generating 2.3B in free cash flow

Areas to Watch

BSX1 concerns · Avg: 4.0/10
P/E RatioValuation
36.0x4/10

Premium valuation, high expectations priced in

HD4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
2.942/10

Expensive relative to growth rate

Price/BookValuation
25.7x2/10

Trading at 25.7x book value

Revenue GrowthGrowth
-3.8%2/10

Revenue declined 3.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : BSX

The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.

Bull Case : HD

The strongest argument for HD centers on Market Cap, Return on Equity, Altman Z-Score.

Bear Case : BSX

The primary concerns for BSX are P/E Ratio.

Bear Case : HD

The primary concerns for HD are Piotroski F-Score, PEG Ratio, Price/Book.

Key Dynamics to Monitor

BSX profiles as a growth stock while HD is a value play — different risk/reward profiles.

HD carries more volatility with a beta of 1.04 — expect wider price swings.

BSX is growing revenue faster at 15.9% — sustainability is the question.

HD generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

BSX scores higher overall (63/100 vs 50/100) and 15.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

The Home Depot Inc

CONSUMER CYCLICAL · HOME IMPROVEMENT RETAIL · USA

The Home Depot, Inc., commonly known as Home Depot, is the largest home improvement retailer in the United States, supplying tools, construction products, and services. The company is headquartered in incorporated Cobb County, Georgia, with an Atlanta mailing address.

Want to dig deeper into these stocks?